American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target Cut to $3.00 by Analysts at HC Wainwright

Adaptimmune Therapeutics (NASDAQ:ADAP) Price Target Cut to $3.00 by Analysts at HC Wainwright

Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) had its price objective dropped by HC Wainwright from $3.50 to $3.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating... More of this article »
Image about American Airlines Group’s (AAL) Hold Rating Reiterated at Jefferies Financial Group

American Airlines Group’s (AAL) Hold Rating Reiterated at Jefferies Financial Group

American Airlines Group (NASDAQ:AAL – Get Free Report)‘s stock had its “hold” rating reissued by stock analysts at Jefferies Financial Group in a report released on Tuesday, Marketbeat Ratings reports. They... More of this article »
Image about Truist Financial Issues Pessimistic Forecast for Autolus Therapeutics (NASDAQ:AUTL) Stock Price

Truist Financial Issues Pessimistic Forecast for Autolus Therapeutics (NASDAQ:AUTL) Stock Price

Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) had its price target cut by stock analysts at Truist Financial from $11.00 to $10.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a... More of this article »
Image about BioNTech (NASDAQ:BNTX) Price Target Lowered to $145.00 at HC Wainwright

BioNTech (NASDAQ:BNTX) Price Target Lowered to $145.00 at HC Wainwright

BioNTech (NASDAQ:BNTX – Get Free Report) had its target price cut by HC Wainwright from $150.00 to $145.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on... More of this article »
Image about DA Davidson Initiates Coverage on BlackLine (NASDAQ:BL)

DA Davidson Initiates Coverage on BlackLine (NASDAQ:BL)

Research analysts at DA Davidson began coverage on shares of BlackLine (NASDAQ:BL – Get Free Report) in a research report issued on Tuesday, Marketbeat Ratings reports. The firm set a “buy” rating and a $58.00 price... More of this article »
Image about Jefferies Financial Group Begins Coverage on Akebia Therapeutics (NASDAQ:AKBA)

Jefferies Financial Group Begins Coverage on Akebia Therapeutics (NASDAQ:AKBA)

Jefferies Financial Group started coverage on shares of Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $6.00 price... More of this article »
Image about Barclays Initiates Coverage on Astrana Health (NASDAQ:ASTH)

Barclays Initiates Coverage on Astrana Health (NASDAQ:ASTH)

Barclays began coverage on shares of Astrana Health (NASDAQ:ASTH – Get Free Report) in a report issued on Tuesday, MarketBeat reports. The firm set an “equal weight” rating and a $36.00 price target on the stock.... More of this article »
Image about Canaccord Genuity Group Begins Coverage on Arbe Robotics (NASDAQ:ARBE)

Canaccord Genuity Group Begins Coverage on Arbe Robotics (NASDAQ:ARBE)

Stock analysts at Canaccord Genuity Group started coverage on shares of Arbe Robotics (NASDAQ:ARBE – Get Free Report) in a research report issued on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating... More of this article »
Image about bioAffinity Technologies’ (BIAF) “Hold” Rating Reaffirmed at Maxim Group

bioAffinity Technologies’ (BIAF) “Hold” Rating Reaffirmed at Maxim Group

bioAffinity Technologies (NASDAQ:BIAF – Get Free Report)‘s stock had its “hold” rating reissued by equities research analysts at Maxim Group in a report issued on Tuesday,Benzinga reports. bioAffinity Technologies... More of this article »
Image about Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,380.50 Consensus PT from Analysts

Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,380.50 Consensus PT from Analysts

Mettler-Toledo International Inc. (NYSE:MTD – Get Free Report) has received a consensus recommendation of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One investment... More of this article »
Image about IDACORP, Inc. (NYSE:IDA) Receives $120.50 Consensus Price Target from Brokerages

IDACORP, Inc. (NYSE:IDA) Receives $120.50 Consensus Price Target from Brokerages

IDACORP, Inc. (NYSE:IDA – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated... More of this article »
Image about Brokerages Set WESCO International, Inc. (NYSE:WCC) PT at $219.43

Brokerages Set WESCO International, Inc. (NYSE:WCC) PT at $219.43

Shares of WESCO International, Inc. (NYSE:WCC – Get Free Report) have received an average rating of “Buy” from the eight brokerages that are currently covering the company, MarketBeat Ratings reports. One investment... More of this article »
Image about Symbotic Inc. (NASDAQ:SYM) Receives $38.20 Consensus PT from Analysts

Symbotic Inc. (NASDAQ:SYM) Receives $38.20 Consensus PT from Analysts

Shares of Symbotic Inc. (NASDAQ:SYM – Get Free Report) have received an average recommendation of “Hold” from the seventeen research firms that are presently covering the company, Marketbeat reports. One equities... More of this article »
Image about Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $167.64 Consensus Price Target from Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $167.64 Consensus Price Target from Brokerages

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has been given a consensus rating of “Buy” by the fifteen analysts that are currently covering the company, MarketBeat Ratings reports. Fifteen investment... More of this article »
Image about Silexion Therapeutics (NASDAQ:SLXN) & Apogee Therapeutics (NASDAQ:APGE) Head-To-Head Comparison

Silexion Therapeutics (NASDAQ:SLXN) & Apogee Therapeutics (NASDAQ:APGE) Head-To-Head Comparison

Silexion Therapeutics (NASDAQ:SLXN – Get Free Report) and Apogee Therapeutics (NASDAQ:APGE – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based... More of this article »